Curofy
93 percent of advanced leukemia patients in remission after immunotherapy
Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers.
See this content immediately after install